Comparative Efficacy of Three 5-HT3 Antagonists (Granisetron, Ondansetron, and Tropisetron) Plus Dexamethasone for the Prevention of Cisplatin-Induced Acute Emesis-Reference-Cited by-同舟云学术

Comparative Efficacy of Three 5-HT3 Antagonists (Granisetron, Ondansetron, and Tropisetron) Plus Dexamethasone for the Prevention of Cisplatin-Induced Acute Emesis

Published:2000-04 Issue:2 Volume:23 Page:185-191
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology: Cancer Clinical Trials
language:en
Short-container-title:American Journal of Clinical Oncology: Cancer Clinical Trials

Author:

Chua Daniel T. T.,Sham Jonathan S. T.,Kwong Dora L. W.,Kwok Carol C. H.,Yue Arthur,Foo Yoke-Ching,Chan Raymond

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference30 articles.

1. Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis

2. Granisetron plus methylprednisolone for the control of high-dose cisplatin-induced emesis

3. A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis.

4. Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis;Cochrane Database of Systematic Reviews;2021-11-16

2. Simultaneous Determination of Dexamethasone, Ondansetron, Granisetron, Tropisetron, and Azasetron in Infusion Samples by HPLC with DAD Detection;Journal of Analytical Methods in Chemistry;2017

3. Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis;Expert Review of Clinical Pharmacology;2016-06-15

4. First-Generation 5-HT3 Receptor Antagonists;Management of Chemotherapy-Induced Nausea and Vomiting;2016

5. Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries;Supportive Care in Cancer;2014-08-14